Skip to Content

Biologics Consulting Welcomes Jenny Xiradakis, B.Sc. Pharm to its CMC Business Unit

May 31, 2022  •  News
Posted In Other News & Insights

Biologics Consulting is pleased to welcome a new member to our CMC Business Unit – Quality and Compliance Group, Ms. Jenny Xiradakis, B.Sc. Pharm. Jenny joins Biologics after 16 years at FDA (CDER), Office of Pharmaceutical Quality/Office of Surveillance, and the Office of Regulatory Affairs, New York District Drug Inspection Group.  Jenny holds a B.Sc. Pharm from Long Island University, and is an expert in CMC regulatory and quality compliance, as well as being a registered Pharmacist and expert in Pharmacy Law.  Her experience ranges across both small molecule and biologics therapeutics.  Biologics Consulting welcomes Jenny to our team and expects that she will represent a significant addition to our CMC Quality group, and our clients.